Flemo Max20 mg+35 mg+200 mg+50 mg+50 mg

Flemo Max is a multi-ingredient dietary supplement intended for adjunct symptomatic support of joint comfort, stiffness, and mobility, particularly in adults with mild, age-related or osteoarthritis-related joint symptoms.

• Traditional/established supportive use: Supportive care for joint stiffness and discomfort associated with normal wear-and-tear or mild osteoarthritis, used alongside standard medical care rather than in place of it.
• Evidence-supported component uses: The individual components of Flemo Max (undenatured type-II collagen, hyaluronic acid, methylsulfonylmethane [MSM], turmeric/curcumin, and Boswellia serrata) each have published clinical studies, generally small-to-moderate in size, suggesting modest benefit for osteoarthritis-related joint pain and function; evidence for the fixed combination as a whole is more limited and largely extrapolated from the individual ingredients.
• Adjunct use: Flemo Max is intended to be used together with, not instead of, physician-directed treatment (e.g., physiotherapy, weight management, prescribed analgesics/NSAIDs) for diagnosed joint disease.
• Not indicated for: Diagnosis or treatment of inflammatory arthritis (e.g., rheumatoid arthritis, gout), acute joint injury, joint infection, or unexplained/worsening joint swelling and pain — these require medical evaluation.

Flemo Max is a dietary/nutritional supplement, not a substitute for medical evaluation and treatment of significant, persistent, or worsening joint pain, swelling, redness, warmth, or loss of function.

Each unit (tablet/capsule, per product label) of Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata typically contains a combination of:

• Undenatured Type-II Collagen (UC-II type)
• Hyaluronic Acid (sodium hyaluronate)
• Methylsulfonylmethane (MSM)
• Turmeric extract (standardized for curcuminoids)
• Boswellia serrata extract (standardized for boswellic acids)

Exact quantities of each ingredient vary by brand/formulation; refer to the specific product label for the precise strength of Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata.

Flemo Max is an oral, multi-ingredient joint-health dietary supplement that combines a cartilage-derived protein (undenatured type-II collagen), a joint-lubricating glycosaminoglycan (hyaluronic acid), an organosulfur compound (MSM), and two plant-derived anti-inflammatory extracts (turmeric/curcumin and Boswellia serrata). Flemo Max is formulated to provide combined nutritional and botanical support for joint structure, comfort, and mobility, and is available in Bangladesh as an over-the-counter nutraceutical, typically in tablet or capsule form.

Flemo Max belongs to the joint-health nutraceutical / dietary supplement combination class (cartilage-support protein + glycosaminoglycan + organosulfur compound + herbal anti-inflammatory extracts); it is not classified as a prescription anti-arthritic drug.

Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata combines ingredients proposed to act through complementary mechanisms:

• Undenatured type-II collagen: Proposed to act via an oral-tolerance/immunomodulatory mechanism in gut-associated lymphoid tissue, potentially down-regulating an immune-mediated inflammatory response to native joint cartilage collagen, distinct from the "building-block" mechanism of hydrolyzed collagen.
• Hyaluronic acid: A major structural component of synovial fluid and cartilage extracellular matrix; oral supplementation is proposed to support joint lubrication and the viscoelastic properties of synovial fluid.
• Methylsulfonylmethane (MSM): An organosulfur compound with proposed anti-inflammatory and antioxidant activity; some clinical trials report modest reductions in osteoarthritis-related pain and improved physical function.
• Turmeric (curcumin): Curcuminoids inhibit pro-inflammatory mediators (e.g., COX-2, the NF-κB pathway, cytokines) in preclinical models; clinical trials in osteoarthritis suggest modest analgesic and anti-inflammatory benefit.
• Boswellia serrata: Boswellic acids inhibit 5-lipoxygenase, reducing leukotriene-mediated inflammation; clinical trials in knee osteoarthritis report improvements in pain and function scores.

Overall clinical evidence for Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata is generally modest and variable in quality, and stronger for individual ingredients (particularly turmeric/curcumin and Boswellia serrata) than for this specific fixed combination.

Take Flemo Max orally, preferably with food and a full glass of water, to minimize the chance of mild gastrointestinal upset. Swallow tablets/capsules whole; do not crush or chew unless the product label specifically permits it.

Because Flemo Max contains turmeric (curcumin), which has mild antiplatelet activity, the following interaction is clinically relevant:

• Anticoagulants and antiplatelet agents (e.g., warfarin, aspirin, clopidogrel, heparin, direct oral anticoagulants): Concurrent use with Flemo Max may theoretically increase bleeding risk due to additive antiplatelet effects; use with caution and inform the prescribing physician before combining.

Other theoretical interactions (e.g., with antidiabetic agents, due to possible mild glucose-lowering effects of curcumin) are less well established; inform your physician or pharmacist of all medicines and supplements being taken before starting Flemo Max.

Flemo Max is generally well tolerated. Reported adverse effects are usually mild and include:

• Mild gastrointestinal upset — nausea, dyspepsia, bloating, diarrhea, or constipation.
• Headache (occasionally reported with turmeric/curcumin).
• Mild skin rash or itching (rare, generally hypersensitivity-related — see Contraindications).

Serious adverse effects with Flemo Max are rare. Discontinue use and seek medical advice if signs of an allergic reaction (rash, swelling, difficulty breathing) occur.

Robust safety data for Flemo Max in pregnancy and lactation are limited, as it is a dietary supplement rather than an extensively studied prescription drug. At typical supplement doses, the individual components are generally considered low risk; however, turmeric/curcumin in concentrated extract form has limited pregnancy safety data and theoretical uterine-stimulant and antiplatelet effects at high doses. Flemo Max should be used during pregnancy or breastfeeding only if clearly needed, after consulting a physician, and only under professional guidance.

Use Flemo Max with the following precautions:

• Flemo Max is a dietary supplement intended for symptomatic support only; it is not a substitute for medical evaluation of significant, persistent, or worsening joint pain, swelling, redness, warmth, fever, or loss of function, which may indicate infection, inflammatory arthritis, or other conditions requiring specific treatment.
• Use with caution in patients on anticoagulant/antiplatelet therapy or with bleeding disorders, due to the antiplatelet potential of the turmeric component (see Interaction).
• Use with caution in patients with gallbladder disease or bile duct obstruction, as turmeric may stimulate bile secretion.
• Discontinue Flemo Max at least 1–2 weeks before elective surgery, given the theoretical bleeding risk from turmeric.
• Not a substitute for standard treatments in diagnosed osteoarthritis or other joint diseases; continue physician-directed care alongside Flemo Max.

Specific overdose data for Flemo Max are not well documented, as significant toxicity from typical supplement overdose is uncommon. Taking substantially more than the labeled dose of Flemo Max may increase the likelihood of gastrointestinal upset (nausea, vomiting, diarrhea, abdominal discomfort) and, theoretically, bleeding risk (due to the turmeric component). If overdose is suspected, or if severe symptoms occur, seek immediate medical attention or contact a poison control center; do not attempt specific home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Flemo Max use across specific populations:

• Pregnancy/lactation: Use only if clearly needed and under medical guidance (see Pregnancy and Lactation).
• Pediatric patients: Safety and efficacy of Flemo Max have not been established in children and adolescents; not recommended for use in this population without physician advice.
• Elderly: A commonly used population for joint-health support; no specific dose adjustment established, but caution advised regarding concurrent anticoagulant use (see Interaction).
• Hepatic impairment: Use with caution; theoretical concern with concentrated turmeric/curcumin extracts in significant liver disease — consult a physician.
• Renal impairment: No well-established dose adjustment; use under medical supervision.
• Bleeding disorders/anticoagulant use: Use with caution due to turmeric's antiplatelet potential (see Interaction and Precautions and Warnings).

A minimum trial of 4–8 weeks of consistent daily use of Flemo Max is generally recommended before assessing benefit, as joint-health supplements typically show gradual rather than immediate effect. Longer-term use (several months) of Flemo Max is common practice for maintenance, under periodic reassessment by a physician; there is no well-established maximum duration, but ongoing joint symptoms should prompt medical re-evaluation rather than indefinite self-treatment.

Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata is a nutraceutical / dietary supplement combination: cartilage-derived structural protein (undenatured type-II collagen) + glycosaminoglycan (hyaluronic acid) + organosulfur compound (MSM) + herbal anti-inflammatory extracts (turmeric/curcumin, Boswellia serrata).

The components of Undenatured Type-II Collagen + Hyaluronic Acid + Methylsulfonylmethane + Turmeric + Boswellia serrata act through complementary, non-identical mechanisms — immune modulation supporting cartilage (collagen), structural/lubricating support (hyaluronic acid), and anti-inflammatory/antioxidant activity (MSM, curcumin, boswellic acids) — see Pharmacology for details.

Safety and efficacy of Flemo Max have not been established in children and adolescents. Flemo Max is not recommended for pediatric use outside of specific physician guidance, as pediatric joint conditions require dedicated medical evaluation rather than self-directed supplementation.